Antonia Pijuan-Domènech, Francesc Baró-Mariné, Mireia Rojas-Torrijos, Laura Dos-Subirà, Valle Pedrosa-Del Moral, Maria Teresa Subirana-Domènech, Maria Goya-Canino, Luis Cabero-Roura, David Garcia-Dorado, Jaume Casaldàliga-Ferrer
The objective of the study is to report the contraceptive methods used by patients with congenital heart disease (CHD) before referral to a specific preconception clinic and evaluate safety and treatment adherence of the alternative contraception method, progesterone-only component (PC), offered. Contraceptive methods in the CHD population reported included estrogen-progesterone combined contraceptives (EPCC), despite the potential risk for thromboembolism. PC has been suggested as an alternative, but, no information on its use has been reported...
August 15, 2013: American Journal of Cardiology